Veracyte locks down insurance coverage for Dx; Solar-powered autoclave could help developing world;

@FierceMedDev: New special report: A look at 2013's hot M&A start. Feature | Follow @FierceMedDev

 @MarkHFierce: It's not easy for Dx outfits to win Medicare coverage in today's market, but Crescendo did. Story | Follow @MarkHFierce

@DamianFierce: Are Intuitive's weak da Vinci sales a hiccup or an omen? Shares slipped 15% overnight. News | Follow @DamianFierce

> The New York Times editorial board has come out in favor of a standardized FDA-approval process for lab-developed diagnostics, warning that the current system puts patients at risk. Column

> Indian patients pay almost twice as much for stents as Americans and Europeans, according to a report. More

> EDP Biotech has partnered with Corgenix to launch ColoMarker, a blood test for colon cancer. News

> Aetna, the nation's third-largest insurer, has agreed to cover Veracyte's Afirma genomic test for thyroid cancer. Story

> A Cornell team has won a $100,000 research prize for MoodRyhthm, an app designed to help patients manage bipolar disorder. More

> Medical device manufacturer Vention Medical has acquired RiverTech Medical, maker of component technologies. Item

> French diagnostics outfit Theradiag has launched two multiplexed molecular diagnostic assays that test for respiratory viruses and infectious gastroenteritis. Release

> Autoclaves have prevented millions of infections since their invention more than 100 years ago, but many in the developing world lack access to the sterilizing devices. Now, two Rice University professors have invented a low-cost, solar-powered autoclave that could sanitize instruments without the need for external power. Article

Biotech News

@FierceBiotech: 'Fraud' found at China site for key study of Pfizer and Bristol's Eliquis. Report | Follow @FierceBiotech

 @JohnCFierce: Amgen commits $50M-plus in 3-way deal to expand cardiovascular drug pipeline. Article | Follow @JohnCFierce

@RyanMFierce: Expert exposes "highly questionable" data from biotech Cardio3 after IPO. ICYMI yesterday | Follow @RyanMFierce

> UniQure snags $58M in collaboration cash plus equity. Item

> Forma enlists expert partners to create a portfolio of virtual cancer biotechs. Report

> GlaxoSmithKline teams with Immunocore on next-gen cancer immunotherapies. News

Pharma News

@FiercePharma: Investors hiss at Pharmstandard spinoff engineering. Plans to buy out investors who oppose OTC deal--at a discount. More | Follow @FiercePharma

 @CarlyHFierce: Alleged Botox marketing strategy in China named for Russian sniper Vasily Zaytsev - anyone seen Enemy at the Gates? More (sub. req.)| Follow @CarlyHFierce

> If Allergan went on the block, would Big Pharma bite? More

> Mylan's $1.6B Agila buyout hits snag in India amid cancer drug worries. Report

> Alzheimer's group pledges fight for Lilly's Amyvid. Article

Pharma Manufacturing News

 @EricPFierce: I'm looking for pharma folks interested in being part of a webinar on how their companies are using marketing apps to talk with clients. Let me know. | Follow @EricPFierce

> Nikkei: Teva to double manufacturing capacity in Japan. More

> Wockhardt faces 2nd import alert. Report

> Hikma New Jersey plant back in production. Article

> Fresenius gets 2nd warning letter in 18 months. Story

Biotech Research News

 @EmilyMFierce: Ohio-based startup Biosortia is tapping into nature to fill early drug-discovery void. Editor's corner | Follow @EmilyMFierce

> U.K. launches large-scale genomics project. More

> Immune modulation could explain how experimental Alzheimer's therapy works. Item

> More positive preclinical results for Inovio's H7N9 vaccine. Story

> New research could help cut cardiovascular risks associated with arthritis drugs. Article

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,